Development and validation of a time-resolved fluorometric immunoassay for screening of antichlamydial activity using a genus-specific europium-conjugated antibody

Analytical Biochemistry

Volumn 333, Issue 1, 2004, Pages 39-48

  Tammela, Päivi ^a   Alvesalo, Joni ^a   Riihimäki, Laura ^a   Airenne, Sari ^b   Leinonen, Maija ^b   Hurskainen, Pertti ^c   Enkvist, Kristian ^c   Vuorela, Pia ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c PerkinElmer Finland Oy   (Finland)

Author keywords

IF staining; MIC evaluation; Real time PCR; Screening; Time resolved fluorescence; TR FIA

Indexed keywords

ANTIBODIES; ANTIMICROBIAL AGENTS; BACTERIA; DIAGNOSIS; EUROPIUM; FLUORESCENCE; IMMUNOLOGY; SCREENING; SIGNAL TO NOISE RATIO;

IF STAINING; MIC EVALUATION; REAL-TIME PCR; TIME-RESOLVED FLUORESCENCE; TR-FIA;

POLYMERASE CHAIN REACTION;

ANTIBODY; ANTIINFECTIVE AGENT; CIPROFLOXACIN; DOXYCYCLINE; ERYTHROMYCIN; EUROPIUM; MINOCYCLINE; OFLOXACIN; PENICILLIN G; RIFAMPICIN; STREPTOMYCIN; SULFORHODAMINE B;

ANALYTIC METHOD; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ANTIBODY LABELING; ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; CHLAMYDOPHILA PNEUMONIAE; CONJUGATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; EXPERIMENTAL TEST; FLUOROMETRY; GENUS; IMMUNOASSAY; IMMUNOFLUORESCENCE; IN VITRO STUDY; MEASUREMENT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RELIABILITY; REPRODUCIBILITY; SCREENING; SIGNAL NOISE RATIO; TECHNOLOGY; TIME; VALIDATION PROCESS;

CHLAMYDIA; CHLAMYDOPHILA PNEUMONIAE;

EID: 4444257625     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ab.2004.06.012     Document Type: Article

References (48)

1. P. Saikku, M. Leinonen, K. Mattila, M.S. Nieminen, J.K. Huttunen, and V. Valtonen Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction Lancet 2 1988 983 986
2. J.T. Grayston, C.C. Kuo, A.S. Coulson, L.A. Campbell, R.D. Lawrence, M.J. Lee, E.D. Strandness, and S.P. Wang Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery Circulation 92 1995 3397 3400
3. M. Maass, C. Bartels, P.M. Engel, U. Mamat, and H.H. Sievers Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease J. Am. Coll. Cardiol. 31 1998 827 832
4. P. Saikku Chlamydia pneumoniae in atherosclerosis J. Int. Med. 247 2000 391 396
5. D.L. Hahn, R.W. Dodge, and R. Golubjatnikov Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma JAMA 266 1991 225 230
6. D.L. Hahn, T. Anttila, and P. Saikku Association of Chlamydia pneumoniae IgA antibodies with recently symptomatic asthma Epidemiol. Infect. 117 1996 513 517
7. P.J. Cook, P. Davies, W. Tunnicliffe, J.G. Ayres, D. Honeybourne, and R. Wise Chlamydia pneumoniae and asthma Thorax 53 1998 254 259
8. L. von Hertzen, M. Töyrylä, A. Gimishanov, A. Bloigu, M. Leinonen, P. Saikku, and T. Haahtela Asthma, atopy, and Chlamydia pneumoniae antibodies in adults Clin. Exp. Allergy 29 1999 522 528
9. L. von Hertzen, T. Vasankari, K. Liippo, E. Wahlström, and M. Puolakkainen Chlamydia pneumoniae and severity of asthma Scand. J. Infect. Dis. 34 2002 22 27
10. M. Koskiniemi, M. Gencay, O. Salonen, M. Puolakkainen, M. Färkkilä, P. Saikku, and A. Vaheri Chlamydia pneumoniae associated with central nervous system infections Eur. Neurol. 36 1996 160 163
11. B.J. Balin, H.C. Gérard, E.J. Arking, D.M. Appelt, P.J. Branigan, J.T. Abrams, J.A. Whittum-Hudson, and A.P. Hudson Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain Med. Microbiol. Immunol. 187 1998 23 42
12. M.R. Hammerschlag Chlamydia pneumoniae and the lung Eur. Respir. J. 16 2000 1001 1007
13. M.A. Khan, C.W. Potter, and R.M. Sharrard A reverse transcriptase-PCR based assay for in vitro antibiotic susceptibility testing of Chlamydia pneumoniae J. Antimicrob. Chemother. 37 1996 677 685
14. C.M. Black, P.I. Fields, T.O. Messmer, and B.P. Berdal Detection of Chlamydia pneumoniae in clinical specimens by polymerase chain reaction using nested primers Eur. J. Clin. Microbiol. Infect. Dis. 13 1994 752 756
15. C.A. Jantos, R. Roggendorf, F.N. Wuppermann, and J.H. Hegemann Rapid detection of Chlamydia pneumoniae by PCR-enzyme immunoassay J. Clin. Microbiol. 36 1998 1890 1894
16. Y. Kuoppa, J. Boman, L. Scott, U. Kumlin, I. Eriksson, and A. Allard Quantitative detection of respiratory Chlamydia pneumoniae infection by real-time PCR J. Clin. Microbiol. 40 2002 2273 2274
17. M.L.C. Tondella, D.F. Talkington, B.P. Holloway, S.F. Dowell, K. Cowley, M. Soriano-Gabarro, M.S. Elkind, and B.S. Fields Development and evaluation of real-time PCR-based fluorescence assays for detection of Chlamydia pneumoniae J. Clin. Microbiol. 40 2002 575 583
18. P. Apfalter, W. Barousch, M. Nehr, A. Makristathis, B. Willinger, M. Rotter, and A.M. Hirschl Comparison of a new quantitative ompA-based real-time PCR TaqMan assay for detection of Chlamydia pneumoniae DNA in respiratory specimens with four conventional PCR assays J. Clin. Microbiol. 41 2003 592 600
19. N.A. Cross, D.J. Kellock, G.R. Kinghorn, M. Taraktchoglou, E. Bataki, K.M. Oxley, P.M. Hawkey, and A. Eley Antimicrobial susceptibility testing of Chlamydia trachomatis using a reverse transcriptase PCR-based method Antimicrob. Agents Chemother. 43 1999 2311 2313
20. E. Soini, and H. Kojola Time-resolved fluorometer for lanthanide chelates: a new generation of non-isotopic immunoassays Clin. Chem. 29 1983 65 68
21. I. Hemmilä, S. Dakubu, V.M. Mukkala, H. Siitari, and T. Lövgren Europium as a label in time-resolved immunofluorometric assays Anal. Biochem. 137 1984 335 343
22. I.A. Hemmilä, and P. Hurskainen Novel detection strategies for drug discovery Drug Discov. Today 7 2002 S150 S156
23. K. Saarinen, K. Kivistö, K. Blomberg, K. Punnonen, and L. Leino Time-resolved fluorometric assay for leukocyte adhesion using a fluorescence enhancing ligand J. Immunol. Methods 236 2000 19 26
24. K. Blomberg, C. Granberg, I. Hemmilä, and T. Lövgren Europium-labelled target cells in an assay of natural killer cell activity: I. A novel non-radioactive method based on time-resolved fluorescence J. Immunol. Methods 86 1986 225 229
25. G.J. Bouma, P.M.W. Van der Meer-Prins, F.P.M.J. Van Bree, J.J. Van Rood, and F.H.J. Claas Determination of cytotoxic T-lymphocyte precursor frequencies using europium labelling as nonradioactive alternative to labelling with chromium-51 Human Immunol. 35 1992 85 92
26. L. Trinh, R. Ziegler, D. Watling, R.M. Snider, and E. Croze Development of an immunofluorometric, high-capacity, cell-based assay for the measurement of human type I and type II interferons J. Biomol. Screen. 4 1999 33 37
27. J.H. Zhang, T.D.Y. Chung, and K.R. Oldenburg A simple statistical parameter for use in evaluation and validation of high throughput screening assays J. Biomol. Screen. 4 1999 67 73
28. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J.T. Warren, H. Bokesch, S. Kenney, and M.S. Boyd New colorimetric cytotoxicity assay for anticancer-drug screening J. Natl. Cancer Inst. 82 1990 1107 1112
29. S. Bollini, J.J. Herbst, G.T. Gaughan, T.A. Verdoorn, J. Ditta, G.M. Dubowchik, and A. Vinitsky High-throughput fluorescence polarization method for identification of FKBP12 ligands J. Biomol. Screen. 7 2002 526 530
30. J.T. Grayston, L.A. Campbell, C.C. Kuo, C.H. Mordhorst, P. Saikku, D.H. Thom, and S.P. Wang A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR J. Infect. Dis. 161 1990 618 625
31. J. Gieffers, W. Solbach, and M. Maass In vitro susceptibilities of Chlamydia pneumoniae strains recovered from atherosclerotic coronary arteries Antimicrob. Agents Chemother. 42 1998 2762 2764
32. M.R. Hammerschlag, K.K. Qumei, and P.M. Roblin In vitro activities of azithromyzin, clarithromycin, l-ofloxacin, and other antibiotics against Chlamydia pneumoniae Antimicrob. Agents Chemother. 36 1992 1573 1574
33. M. Kimura, T. Kishimoto, Y. Niki, and R. Soejima In vitro and in vivo antichlamydial activities of newly developed quinolone antimicrobial agents Antimicrob. Agents Chemother. 37 1993 801 803
34. M.R. Hammerschlag Antimicrobial susceptibility and therapy of infections caused by Chlamydia pneumoniae Antimicrob. Agents Chemother. 38 1994 1873 1878
35. P.M. Roblin, A. Kutlin, N. Sokolovskaya, and M.R. Hammerschlag In vitro activity of dirithromycin against Chlamydia pneumoniae J. Antimicrob. Chemother. 39 1997 647 649
36. J. Gnarpe, K. Eriksson, and H. Gnarpe In vitro activities of azithromyzin and doxycycline against 15 isolates of Chlamydia pneumoniae Antimicrob. Agents Chemother. 40 1996 1843 1845
37. I.A. Critchley, M.E. Jones, P.D. Heinze, D. Hubbard, H.D. Engler, A.T. Evangelista, C. Thornsberry, J.A. Karlowsky, and D.F. Sahm In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae, and Chlamydia pneumoniae from North America and Europe Clin. Microbiol. Infect. 8 2002 214 221
38. K. Nakata, Y. Okazaki, H. Hattori, and S. Nakamura Protective effects of sparfloxacin in experimental pneumonia caused by Chlamydia pneumoniae in leukopenic mice Antimicrob. Agents Chemother. 38 1994 1757 1762
39. P. Apfalter, O. Assadian, F. Blasi, J. Boman, C.A. Gaydos, M. Kundi, A. Makristathis, M. Nehr, M.L. Rotter, and A.M. Hirschl Reliability of nested PCR for detection of Chlamydia pneumoniae DNA in atheromas: results from a multicenter study applying standardized protocols J. Clin. Microbiol. 40 2002 4428 4434
40. J. Huang, F.J. DeGraves, D. Gao, P. Feng, T. Schlapp, and B. Kaltenboeck Quantitative detection of Chlamydia spp. by fluorescent PCR in the LightCycler BioTechniques 30 2001 150 157
41. J.M. Rolain, L. Sthul, M. Maurin, and D. Raoult Evaluation of antibiotic susceptibilities of three rickettsial species including Rickettsia felis by a quantitative PCR DNA assay Antimicrob. Agents Chemother. 46 2002 2747 2751
42. F. Fenollar, M. Maurin, and D. Raoult Wolbachia pipientis growth kinetics and susceptibilities to 13 antibiotics determined by immunofluorescence staining and real-time PCR Antimicrob. Agents Chemother. 47 2003 1665 1671
43. R.E. Brennan, and J.E. Samuel Evaluation of Coxiella burnetii antibiotic susceptibilities by real-time PCR assay J. Clin. Microbiol. 41 2003 1869 1874
44. M.R. Hammerschlag, C.L. Hyman, and P.M. Roblin In vitro activities of five quinolones against Chlamydia pneumoniae Antimicrob. Agents Chemother. 36 1992 682 683
45. A.J. McCoy, R.C. Sandlin, and A.T. Maurelli In vitro and in vivo functional activity of Chlamydia MurA, a UDP-N-acetylglucosamine enolpyruvyl transferase involved in peptidoglycan synthesis and fosfomycin resistance J. Bacteriol. 185 2003 1218 1228
46. I. Chopra, C. Storey, T.J. Falla, and J.H. Pearce Antibiotics, peptidoglycan synthesis, and genomics: the chlamydial anomaly revisited Microbiology 144 1998 2673 2678
47. A. Matsumoto, and G.P. Manire Electron microscopic observations of the effects of penicillin on the morphology of Chlamydia psittaci J. Bacteriol. 101 1970 278 285
48. A. Kutlin, P.M. Roblin, and M.R. Hammerschlag Effect of prolonged treatment with azithromycin, clarithromycin, or levofloxacin on Chlamydia pneumoniae in a continuous-infection model Antimicrob. Agents Chemother. 46 2002 409 412